Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Studies from College of Medicine describe new findings in cancer vaccines
April 8th, 2008
A report, 'Acquired immune response to oncogenic human papillomavirus associated with prophylactic cervical cancer vaccines,' is newly published data in Cancer Immunology, Immunotherapy. "Human papillomavirus (HPV) is a common infection among women and a necessary cause of cervical cancer. Oncogenic HPV types infecting the anogenital tract have the potential to induce natural immunity, but at present we do not clearly understand the natural history of infection in humans and the mechanisms by which the virus can evade the host immune response," investigators in the United States report. "Natural acquired immune responses against HPV may be involved in the...
Source: Cancer Weekly (2008-04-08)
|
